Bulletin
Investor Alert

New York Markets Open in:

MemeMoney Archives | Email alerts

Nov. 23, 2021, 6:02 p.m. EST

Some squeeze-loving retail investors are being cautious about all those shorts on Longeveron

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Longeveron Inc. (LGVN)
  • X
    Ocugen Inc. (OCGN)
  • X
    Phunware Inc. (PHUN)

or Cancel Already have a watchlist? Log In

By Thornton McEnery

It’s never fair to paint all retail investors with the same brush, but it’s also rather fair to say that pretty much all retail investors love themselves a short squeeze.

But in the case of a little-known biopharma stock Longeveron /zigman2/quotes/224642771/composite LGVN +3.06% , many retail “Apes” on social media are looking at a short-squeeze opportunity that appears perhaps too good to be true…or too short to be squozed?

Longeveron shares began to rocket upward last Thursday after the company announced the Food and Drug Administration had given the green light for its drug Lomecel-B to be used in the treatment of Hypoplastic Left Heart Syndrome, a congenital heart defect in infants that affects roughly 1,000 babies every year.

That rather narrow use-case upside had a much larger effect on the stock price, which gained more than 850% over three torrid days of trading going into Tuesday.

The heavily shorted stock also benefited from — you guessed it! — increased social-media chatter.

But as we’ve come to learn from the last few months, not all meme-stock momentum is as authentically viral as it might first appear.

In fact, because Longeveron is so niche and the market cap is so small, many investors on Reddit saw the initial move higher, and many posts about it, as “shilling” or” spamming,” terms that Reddit Apes use to denote bad actors playing with the power of meme stocks to create one out whole cloth.

“Spam doesnt work, just stop,” moaned ArlendmcFarland on subreddit r/Shortsqueeze in response to a post pitching LGVN as a huge short-squeeze candidate before the market’s open on Tuesday.

Retail investors have also become sensitive to biopharma plays after meme round-trips on stocks like Ocugen /zigman2/quotes/208160861/composite OCGN +5.72% , among others. They are also more generally cautious about squeezing super-small-cap outfits like they did most recently with Phunware /zigman2/quotes/202053060/composite PHUN +3.58% .

Still, some posts on Reddit showed a pretty…uniquely thought-out case for squeezing Longerveron.

“LGVN – 110% SHORT INTREST – 3 SHORT SQUEEZE SIGNALS – 100% UTILIZATION – COST TO BORROW WENT TO 450% INCREDIABLE 2.7MILLION FLOAT – all in maybe squeeze harder then yesturday” postulated user michaeldaversa999 Tuesday morning.

After Tuesday’s bell, however, those concerned about piling into LGVN looked prescient.

Shares in Longeveron closed down 38.9% on Tuesday after falling as much 47.5% on the day.

But the short sellers might have overplayed their hand.

According to data from Ortex, which made the rounds on social media close to Tuesday’s closing bell, the short interest on Longeveron had surged to almost 120% of the free float, a number that brought to mind the heady days of GameStop /zigman2/quotes/203755179/composite GME -4.76% in January, and prompting retail investors to ponder how short sellers can once again short more shares than are available without creating synthetic shares or naked shorting.

To be fair, Longeveron has a comparatively tiny float, with a market cap of just under $330 million even after its recent massive gains, so it’s a pretty narrow battlefield, but the 120% was just too much for some to ignore.

In the first few minutes of after-hours trading on Tuesday, volume on Longeveron stood at 11 million shares, already easily exceeding the stock’s daily average, signaling that options action on the tiny biopharma play had fully caught fire, pushing the stock up more than 3% in 5 minutes before it tanked once again.

But while we fully expect some meme-ish skirmishing in LGVN shares on Wednesday, even the most squeeze-thirsty Apes are looking at the stock and thinking:

“Worth buying back into lgvn?” asked user u/JonMorrison85 around midday Tuesday. “Looks like it’s formed a good bottom here. Trying to decide if I should jump back in or not. Still has huge potential.”

Fellow Apes preached caution.

“Idk? I’m going to sideline this one until I see a good entry, too much potential to tumble back to sub $15 so I’ll wait it out,” responded kaitrix22.

And one thing meme squeezers might want to take into account on Wednesday is that they’re dealing with the first real holiday market week since January’s squeeze.

That potential lack of widespread retail investor engagement as U.S. markets prepare for Turkey Day, was visible in shares of ur-meme AMC Entertainment /zigman2/quotes/200235402/composite AMC -0.44% , which fell more than 5% after trading just over half of its average daily volume.

And GameStop fared even worse on Tuesday, closing down 13.6% after trading volume appeared to fall off a cliff after a chaotic open and falling short interest.

All in all, the pre-holiday hum around meme stocks is setting up a very intriguing pre-Thanksgiving humpday.

/zigman2/quotes/224642771/composite
US : U.S.: Nasdaq
$ 9.08
+0.27 +3.06%
Volume: 780,256
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$178.71 million
Rev. per Employee
$189,737
loading...
/zigman2/quotes/208160861/composite
US : U.S.: Nasdaq
$ 4.25
+0.23 +5.72%
Volume: 11.90M
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$846.54 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/202053060/composite
US : U.S.: Nasdaq
$ 2.89
+0.10 +3.58%
Volume: 13.92M
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$278.19 million
Rev. per Employee
$125,172
loading...
/zigman2/quotes/203755179/composite
US : U.S.: NYSE
$ 116.65
-5.83 -4.76%
Volume: 3.85M
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
0.00%
Market Cap
$8.91 billion
Rev. per Employee
$489,908
loading...
/zigman2/quotes/200235402/composite
US : U.S.: NYSE
$ 20.57
-0.09 -0.44%
Volume: 57.00M
Jan. 14, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
0.00%
Market Cap
$10.57 billion
Rev. per Employee
$53,348
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

World News from MarketWatch

Link to MarketWatch's Slice.